Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-12-01, Stock:JNJ, The news for the past five days is as follows:
2021-11-23: NEWS1: COVID-19 vaccines have ‘proved their merit at this point’: Doctor.NEWS2: Top Analyst Reports for Johnson & Johnson, Netflix & Oracle.NEWS3: Countries pushing vaccine IP waivers ‘want to take advantage of the technology’: Fmr. U.S. Commerce Secretary.NEWS4: COVID-19: The U.S. issues advisory for travel to Europe but has no plans for a lockdown.NEWS5: COVID-19: The U.S. issues advisory for travel to Europe but has no plans for a lockdown.NEWS6: Will Investors Benefit From Johnson & Johnson's Breakup?.NEWS7: 4 Reasons Arrowhead Pharmaceuticals Could Be the Next Biotech Buyout.
2021-11-24: NEWS1: COVID-19: ‘Vaccines absolutely decrease the risk of transmission’, doctor says.NEWS2: Mario Gabelli says more companies will catch the 'contagion' to split up — watch for these 4 potentially lucrative breakups.NEWS3: 10 Blue Chip Dividend Stocks with Over 8% Yield.NEWS4: The Key Issues in Picking an Active or Passive Fund.NEWS5: Germany mulls a lockdown as COVID cases rise in Europe.NEWS6: U.S. has already seen more COVID deaths in 2021 than 2020 before vaccines were available, as experts again warn pandemic is not over.NEWS7: Canada clears import of J&J COVID-19 vaccine doses made at Emergent plant.NEWS8: UPDATE 2-Canada clears import of J&J COVID-19 vaccine doses made at Emergent plant.NEWS9: Johnson & Johnson COVID vaccine wins full approval in Canada in first major regulatory nod.NEWS10: UPDATE 2-Canada gives full approval to J&J's single-shot COVID-19 vaccine.NEWS11: The Zacks Analyst Blog Highlights: Johnson & Johnson, Netflix, Oracle, PepsiCo and Verizon Communications.NEWS12: CVS, Walmart Fall as Ohio Jury Rules Them Guilty in Opioid Crisis.
2021-11-26: NEWS1: What the newly discovered COVID-19 variants means for investors: Stifel chief equity strategist.NEWS2: Vaccines 'still the backbone of everything we do' amid any variants, doctor explains.NEWS3: Market selloff: COVID-19 news 'caught people by surprise' on shortened day, strategist explains.NEWS4: Stocks fall, Merck drops on COVID-19 pill effectiveness, air travel hits pandemic high, more PPP fraud.NEWS5: Airlines and cruises take a hit, Zoom and vaccine stocks up.NEWS6: Hospital capacity is key for COVID-19 containment going forward: Oppenheimer analyst.NEWS7: 'Travel bans don't work,' doctor explains amid reports of newly discovered variant.NEWS8: Market strategist details 'the critical issue' to understand about risk from new COVID-19 variant.NEWS9: Better Buy: Johnson & Johnson or All 30 Dow Jones Stocks?.NEWS10: Stocks down after discovery of new COVID-19 variant.NEWS11: Pfizer/BioNTech's COVID Jab Gets CHMP Nod for Kids Aged 5-11.NEWS12: Pharma Stock Roundup: FDA Nod to COVID Jab for All Adults, CHMP Nod to Shot for Kids.NEWS13: Here's Why We Think Johnson & Johnson (NYSE:JNJ) Is Well Worth Watching.
2021-11-29: NEWS1: Doctor explains Omicron and the possibility of more COVID-19 variants.NEWS2: US STOCKS-Wall Street rebounds after virus-related sell-off.NEWS3: UPDATE 4-U.S. CDC says all adults should get COVID-19 booster shots.NEWS4: Key takeaways from President Biden's comments on new COVID-19 variant.NEWS5: Omicron: What we know so far about the new COVID-19 variant.NEWS6: Omicron variant may mean stock market rally is on hold: Goldman Sachs.NEWS7: Omicron Variant Has Covid-19 Vaccine Makers Preparing for Worst Case.NEWS8: Omicron variant: ‘There probably are cases’ in the U.S. but not yet in large numbers, professor says.NEWS9: UPDATE 4-Biden warns against Omicron panic, pledges no new lockdowns.NEWS10: Rep. Perlmutter (D-CO) talks COVID, Build Back Better bill, the debt ceiling, and marijuana reform.NEWS11: BioNTech, Pfizer, J&J and Moderna Developing Omicron Vaccines.NEWS12: Another COVID wave could depress consumer spending, labor force participation: Economist.NEWS13: Omicron variant: The U.S. travel ban ‘makes no sense at all,’ doctor says.NEWS14: UPDATE 1-South Africa's Aspen in advanced talks over COVID-19 vaccine deal.NEWS15: COVID: 'The big concern is Delta — Omicron is not even here yet,' epidemiologist says.NEWS16: South Africa's Aspen in advanced talks over COVID-19 vaccine deal.NEWS17: UPDATE 1-COVID-19 vaccine makers start work on Omicron-tailored shots.NEWS18: COVID: Breaking down early data on Omicron variant.NEWS19: Confused about whether to get a COVID booster? Here’s what to know.
2021-11-30: NEWS1: U.S. administers 460.7 mln doses of COVID-19 vaccines - CDC.NEWS2: Johnson & Johnson Announces Significant Progress Towards Its Climate Goals - 100% Renewable Electricity for All Sites in the United States, Canada and Europe by 2023.NEWS3: Moderna CEO says vaccines likely less effective against Omicron COVID-19 variant.NEWS4: Omicron: 'Time will tell' as we learn more about transmissibility and risk, doctor explains.NEWS5: 'The market doesn't like an information vacuum, and now we have two,' strategist says.NEWS6: UPDATE 1-Slovenia set to ban Janssen vaccine after woman's death.NEWS7: Slovenia set to ban Janssen vaccine after woman's death.NEWS8: These 3 Stocks Have Underperformed the Market This Year. Is Now the Time to Buy?.NEWS9: ‘We can’t have countries lingering at 10%' COVID-19 vaccination, Columbia professor explains.NEWS10: J&J (JNJ) to Explore Omicron Version of its COVID Vaccine.NEWS11: Stocks fall as investors try to gauge Omicron risk, ongoing supply chain issues.NEWS12: Market strategist: Investors ‘don’t want to overreact’ amid Omicron uncertainty.NEWS13: REFILE-UPDATE 3-S.Africa's Aspen signs deal paving way for J&J COVID vaccine licence.NEWS14: S.Africa's Aspen signs non-binding agreement with J&J for COVID vaccine license.

Answer: Rise